Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies

[1]  Marshall W. Anderson,et al.  Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies , 2017, Genes.

[2]  I. Balcells,et al.  MicroRNA Genetic Variation: From Population Analysis to Functional Implications of Three Allele Variants Associated with Cancer , 2016, Human mutation.

[3]  Hongliang Liu,et al.  Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium. , 2016, Carcinogenesis.

[4]  Manolis Kellis,et al.  HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease , 2015, Nucleic Acids Res..

[5]  K. Matsuo,et al.  Impact of metallothionein gene polymorphisms on the risk of lung cancer in a Japanese population , 2015, Molecular carcinogenesis.

[6]  L. Yang,et al.  Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China. , 2015, Genetics and molecular research : GMR.

[7]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[8]  Jun Yokota,et al.  Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer. , 2015, Cancer research.

[9]  Fuqiang Wen,et al.  The association between the rs6495309 polymorphism in CHRNA3 gene and lung cancer risk in Chinese: a meta-analysis , 2014, Scientific Reports.

[10]  F. Dehghanian,et al.  Association between XPD (Lys751G1n) Polymorphism and Lung Cancer Risk: A Population-Based Study in Iran , 2014, Cell journal.

[11]  Yifeng Zhou,et al.  Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonary disease and lung cancer development in Chinese population. , 2014, Mutagenesis.

[12]  Jun-gang Zhao,et al.  The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population , 2014, Medical Oncology.

[13]  A. Ruano-Raviña,et al.  Genetic Susceptibility, Residential Radon, and Lung Cancer in a Radon Prone Area , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  Baosen Zhou,et al.  Genetic polymorphisms of TERT and CLPTM1L, cooking oil fume exposure, and risk of lung cancer: a case–control study in a Chinese non-smoking female population , 2014, Medical Oncology.

[15]  Mohammad Safiqul Islam,et al.  Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population , 2014, Tumor Biology.

[16]  M. Unsal,et al.  Effects of leptin and leptin receptor gene polymorphisms on lung cancer , 2014, Tumor Biology.

[17]  Wei Wu,et al.  N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males , 2014, Medical Oncology.

[18]  Shicheng Guo,et al.  9q33.3, A Stress-Related Chromosome Region, Contributes to Reducing Lung Squamous Cell Carcinoma Risk , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  Baosen Zhou,et al.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case–control study in northeast Chinese male population , 2014, Medical Oncology.

[20]  Wei Wu,et al.  Single Nucleotide Polymorphism in ATM Gene, Cooking Oil Fumes and Lung Adenocarcinoma Susceptibility in Chinese Female Non-Smokers: A Case-Control Study , 2014, PloS one.

[21]  Ji-fan Hu,et al.  Cancer Stem Cell Marker Musashi-1 rs2522137 Genotype Is Associated with an Increased Risk of Lung Cancer , 2014, PloS one.

[22]  H. Tian,et al.  LAPTM4B polymorphism is associated with non‑small cell lung cancer susceptibility and prognosis. , 2014, Oncology reports.

[23]  Y. Qiao,et al.  Polymorphisms in DNA repair genes of XRCC1, XPA, XPC, XPD and associations with lung cancer risk in Chinese people , 2014, Thoracic cancer.

[24]  Ying Wang,et al.  Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population , 2014, Medical Oncology.

[25]  Yi Zhou,et al.  Glutathione S-Transferase T1 and M1 Polymorphisms Are Associated with Lung Cancer Risk in a Gender-Specific Manner , 2014, Oncology Research and Treatment.

[26]  Lei Cao,et al.  Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer , 2014, Molecular Cancer.

[27]  B. Saikia,et al.  Interaction of XRCC1 and XPD gene polymorphisms with lifestyle and environmental factors regarding susceptibility to lung cancer in a high incidence population in North East India. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[28]  Jin-Fu Xu,et al.  Interaction between smoking and CYP2C19*3 polymorphism increased risk of lung cancer in a Chinese population , 2014, Tumor Biology.

[29]  Haiyan Guo,et al.  Association of miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population. , 2014, Acta biochimica et biophysica Sinica.

[30]  M. Gonsebatt,et al.  Genetic Susceptibility to Lung Cancer Based on Candidate Genes in a Sample from the Mexican Mestizo Population: A Case–Control Study , 2014, Lung.

[31]  Yifeng Zhou,et al.  Effects of a functional variant c.353T>C in snai1 on risk of two contextual diseases. Chronic obstructive pulmonary disease and lung cancer. , 2014, American journal of respiratory and critical care medicine.

[32]  J. Li,et al.  TERT rs2736100T/G polymorphism upregulates interleukin 6 expression in non-small cell lung cancer especially in adenocarcinoma , 2014, Tumor Biology.

[33]  U. Vogel,et al.  HapMap-based study identifies risk sub-region on chromosome 19q13.3 in relation to lung cancer among Chinese. , 2013, Cancer epidemiology.

[34]  X. Shu,et al.  Effects of polymorphisms in translesion DNA synthesis genes on lung cancer risk and prognosis in Chinese men. , 2013, Cancer Epidemiology.

[35]  Baosen Zhou,et al.  TP63 gene polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese non-smoking females. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[36]  Man Jiang,et al.  Association between the Telomerase Reverse Transcriptase (TERT) rs2736098 Polymorphism and Cancer Risk: Evidence from a Case-Control Study of Non-Small-Cell Lung Cancer and a Meta-Analysis , 2013, PloS one.

[37]  Yifeng Zhou,et al.  Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese , 2013, Molecular carcinogenesis.

[38]  X. Miao,et al.  Genetic variations in TERT‐CLPTM1L locus are associated with risk of lung cancer in chinese population , 2013, Molecular carcinogenesis.

[39]  Lei Yang,et al.  Functional Genetic Polymorphisms in PP2A Subunit Genes Confer Increased Risks of Lung Cancer in Southern and Eastern Chinese , 2013, PloS one.

[40]  X. Miao,et al.  The SNP rs402710 in 5p15.33 Is Associated with Lung Cancer Risk: A Replication Study in Chinese Population and a Meta-Analysis , 2013, PloS one.

[41]  Jian Wang,et al.  Genetic Variants in MUC4 Gene Are Associated with Lung Cancer Risk in a Chinese Population , 2013, PloS one.

[42]  J. Muscat,et al.  A functional trinucleotide repeat polymorphism in the 5′‐untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers , 2013, Molecular carcinogenesis.

[43]  F. Sassi,et al.  Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study. , 2013, Human immunology.

[44]  M. M. Yongjun Zhang,et al.  Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population. , 2013, Journal of cancer research and therapeutics.

[45]  O. Ozdemır,et al.  Combined germline variations of thrombophilic genes promote genesis of lung cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[46]  K. Jamil,et al.  The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[47]  Yong-Jun Zhang,et al.  No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[48]  Yifeng Zhou,et al.  A functional polymorphism in the promoter of ERK5 gene interacts with tobacco smoking to increase the risk of lung cancer in Chinese populations. , 2013, Mutagenesis.

[49]  Tangchun Wu,et al.  Genetic Variation in BCL2 3′-UTR Was Associated with Lung Cancer Risk and Prognosis in Male Chinese Population , 2013, PloS one.

[50]  W. Zheng,et al.  Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence , 2013, Gut.

[51]  Miao Yu,et al.  The Joint Effect of hOGG1, APE1, and ADPRT Polymorphisms and Cooking Oil Fumes on the Risk of Lung Adenocarcinoma in Chinese Non-Smoking Females , 2013, PloS one.

[52]  Li Guo,et al.  Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese women. , 2013, Gene.

[53]  Bin Wang,et al.  Contributory Role of Five Common Polymorphisms of RAGE and APE1 Genes in Lung Cancer among Han Chinese , 2013, PloS one.

[54]  R. Salgia,et al.  Lack of Association of C-Met-N375S Sequence Variant with Lung Cancer Susceptibility and Prognosis , 2013, International journal of medical sciences.

[55]  J. Wu,et al.  Polymorphism rs7214723 in CAMKK1 and lung cancer risk in Chinese population , 2013, Tumor Biology.

[56]  Md. Asaduzzaman Khan,et al.  Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population , 2013, Tumor Biology.

[57]  Haiquan Chen,et al.  CYP19A1 gene polymorphisms and risk of lung cancer , 2013, The Journal of international medical research.

[58]  O. Demirhan,et al.  There is no Significant Association Between Death Receptor 4 (DR4) Gene Polymorphisms and Lung Cancer in Turkish Population , 2013, Pathology & Oncology Research.

[59]  Zuo-Feng Zhang,et al.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer--a case-control study in a Chinese population. , 2013, Lung cancer.

[60]  Xiaoai Zhang,et al.  The p73 G4C14‐to‐A4T14 polymorphism is associated with risk of lung cancer in the Han nationality of North China , 2013, Molecular carcinogenesis.

[61]  Yifeng Zhou,et al.  A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese. , 2013, Human molecular genetics.

[62]  A. Gulsvik,et al.  Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations , 2013, International journal of cancer.

[63]  M. Spitz,et al.  Role of Selected Genetic Variants in Lung Cancer Risk in African Americans , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[64]  M. Spitz,et al.  Pilot Study of CYP2B6 Genetic Variation to Explore the Contribution of Nitrosamine Activation to Lung Carcinogenesis , 2013, International journal of molecular sciences.

[65]  Jinping Zhao,et al.  Serum C-reactive protein and risk of lung cancer: a case–control study , 2013, Medical Oncology.

[66]  Ya-jun Yang,et al.  Significant association of 5p15.33 (TERT–CLPTM1L genes) with lung cancer in Chinese Han population , 2013, Experimental lung research.

[67]  Sachin Kumar,et al.  Polymorphism Arg72Pro of p53 confers susceptibility to squamous cell carcinoma of lungs in a North Indian population. , 2013, DNA and cell biology.

[68]  Marina Vannucci,et al.  Investigating Multiple Candidate Genes and Nutrients in the Folate Metabolism Pathway to Detect Genetic and Nutritional Risk Factors for Lung Cancer , 2013, PloS one.

[69]  Jie Ma,et al.  The genetic variant rs401681C/T is associated with the risk of non-small cell lung cancer in a Chinese mainland population. , 2013, Genetics and molecular research : GMR.

[70]  Wei Ping,et al.  Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations. , 2013, Biochemical and biophysical research communications.

[71]  Q. Wei,et al.  REV3L 3′UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility , 2013, Oncogene.

[72]  Shi-fang Sun,et al.  Polymorphism of VEGF−460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population , 2013, Medical Oncology.

[73]  B. Shen,et al.  CHRNA5 polymorphism and susceptibility to lung cancer in a Chinese population , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[74]  L. Bierut,et al.  Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 Regions Identifies Functional and Histology-Specific Lung Cancer Susceptibility Loci in African-Americans , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[75]  Yifeng Zhou,et al.  Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. , 2012, Carcinogenesis.

[76]  B. Shen,et al.  Correlation between polymorphisms of nicotine acetylcholine acceptor subunit CHRNA3 and lung cancer susceptibility. , 2012, Molecular medicine reports.

[77]  W. Fan,et al.  Intronic boundary mutation rs430397 cannot affect alternate splicing and is an indecisive risk factor for non-small cell lung cancer. , 2012, Chest.

[78]  E. Bowman,et al.  MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer , 2012, International journal of cancer.

[79]  A. Tardón,et al.  Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study. , 2012, Lung Cancer.

[80]  Jianxin Shi,et al.  Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk , 2012, Cancer.

[81]  M. Spitz,et al.  Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans , 2012, Oncotarget.

[82]  D. Wetter,et al.  Method for Evaluating Multiple Mediators: Mediating Effects of Smoking and COPD on the Association between the CHRNA5-A3 Variant and Lung Cancer Risk , 2012, PloS one.

[83]  Huazong Zeng,et al.  RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC , 2012, PloS one.

[84]  Q. Wei,et al.  Functional Polymorphisms of CHRNA3 Predict Risks of Chronic Obstructive Pulmonary Disease and Lung Cancer in Chinese , 2012, PloS one.

[85]  Lihua Jin,et al.  Association between -276 C/T polymorphism of the ERBB3 gene and lung cancer risk in a Korean population. , 2012, Anticancer research.

[86]  A. Tardón,et al.  Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias , 2012, BMC Cancer.

[87]  Xiao-yan Li,et al.  The effect of lysyl oxidase polymorphism on susceptibility and prognosis of nonsmall cell lung cancer , 2012, Tumor Biology.

[88]  Qin Wang,et al.  CYP1A1 Ile462Val Polymorphism Contributes to Lung Cancer Susceptibility among Lung Squamous Carcinoma and Smokers: A Meta-Analysis , 2012, PloS one.

[89]  Yang Zhao,et al.  Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls , 2012, Human molecular genetics.

[90]  Jiyun Yang,et al.  MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients , 2012, PloS one.

[91]  Jing-yu Chen,et al.  EphB4 gene polymorphism and protein expression in non-small-cell lung cancer. , 2012, Molecular medicine reports.

[92]  Huan-ying Wan,et al.  Genetic polymorphisms of XPD and CDA and lung cancer risk. , 2012, Oncology letters.

[93]  Chunyan He,et al.  Polymorphisms on 8q24 Are Associated with Lung Cancer Risk and Survival in Han Chinese , 2012, PloS one.

[94]  Yusuke Nakamura,et al.  A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population , 2012, Nature Genetics.

[95]  U. Vogel,et al.  Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study. , 2012, Cancer genetics.

[96]  U. Vogel,et al.  A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population. , 2012, Lung cancer.

[97]  A. Scorilas,et al.  The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer , 2012, Tumor Biology.

[98]  yongjun zhang,et al.  Association between C3orf21, TP63 polymorphisms and environment and NSCLC in never-smoking Chinese population. , 2012, Gene.

[99]  Dianke Yu,et al.  Cigarette smoking strongly modifies the association of complement factor H variant and the risk of lung cancer. , 2012, Cancer epidemiology.

[100]  U. Vogel,et al.  Hapmap‐based evaluation of ERCC2, PPP1R13L, and ERCC1 and lung cancer risk in a Chinese population , 2012, Environmental and molecular mutagenesis.

[101]  M. Motovali-Bashi,et al.  Role of CYP1A1 MspI polymorphism in CYP1A1 gene with susceptibility to lung cancer in Iranian patients , 2012 .

[102]  T. Lam,et al.  GSTM1 and GSTT1 copy numbers and mRNA expression in lung cancer , 2012, Molecular carcinogenesis.

[103]  Hui Wang,et al.  Association of Genetic Polymorphisms in the Paraoxonase 1 Gene With the Risk and Prognosis of Non–Small Cell Lung Cancer in Chinese Han Population , 2012, Journal of Investigative Medicine.

[104]  Bin Liu,et al.  A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. , 2012, Carcinogenesis.

[105]  M. Siddiqi,et al.  Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India) , 2012, Tumor Biology.

[106]  Yun Liu,et al.  GPC5 rs2352028 Polymorphism and Risk of Lung Cancer in Han Chinese , 2012, Cancer investigation.

[107]  Vidar Skaug,et al.  Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer. , 2011, Lung Cancer.

[108]  S. Gelmini,et al.  Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers , 2011, Clinical chemistry and laboratory medicine.

[109]  Yifeng Zhou,et al.  The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in southern and eastern chinese populations , 2011, Human mutation.

[110]  Kevin S. Xu,et al.  A Common Genetic Variant (97906C>A) of DAB2IP/AIP1 Is Associated with an Increased Risk and Early Onset of Lung Cancer in Chinese Males , 2011, PloS one.

[111]  M. Spitz,et al.  A Case–Control Study of a Sex-Specific Association between a 15q25 Variant and Lung Cancer Risk , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[112]  J. Xu,et al.  Functionally significant nicotine acetylcholine receptor subunit α5 promoter haplotypes are associated with susceptibility to lung cancer in Chinese , 2011, Cancer.

[113]  Y. Zhen,et al.  C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer , 2011, Oncogene.

[114]  Xin Li,et al.  Genetic variants in MMP9 and TCF2 contribute to susceptibility to lung cancer , 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[115]  M. Spitz,et al.  Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. , 2011, Journal of the National Cancer Institute.

[116]  Jiye Yin,et al.  ABCC1 polymorphism Arg723Gln (2168G > A) is associated with lung cancer susceptibility in a Chinese population , 2011, Clinical and experimental pharmacology & physiology.

[117]  Min-Ho Shin,et al.  p53 codon 72 polymorphism and the risk of lung cancer in a Korean population. , 2011, Lung cancer.

[118]  M. Spitz,et al.  Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. , 2011, Cancer discovery.

[119]  Per Magne Ueland,et al.  Genetic Polymorphisms in 15q25 and 19q13 Loci, Cotinine Levels, and Risk of Lung Cancer in EPIC , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[120]  Wen Tan,et al.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese , 2011, Nature Genetics.

[121]  B. Qian,et al.  Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. , 2011, Lung cancer.

[122]  U. Vogel,et al.  HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population. , 2011, Mutation research.

[123]  K. Tanimoto,et al.  Hypoxia‐inducible factor‐1α polymorphisms are associated with genetic aberrations in lung cancer , 2011, Respirology.

[124]  B. Mittal,et al.  Association of Functionally Important Polymorphism of Microsomal Epoxide Hydrolase Gene (EPHX1) With Lung Cancer Susceptibility , 2011, Cancer investigation.

[125]  J Verschakelen,et al.  The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema , 2011, European Respiratory Journal.

[126]  P. Broderick,et al.  Variation in TP63 is Associated with Lung Adenocarcinoma in the UK Population , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[127]  H. Cui,et al.  Cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms are risk factors for lung cancer in Mongolian and Han population in inner Mongolia , 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[128]  Wei Zheng,et al.  Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. , 2011, The Lancet. Oncology.

[129]  P. Broderick,et al.  Chromosome 15q25 (CHRNA3-CHRNA5) Variation Impacts Indirectly on Lung Cancer Risk , 2011, PloS one.

[130]  Paolo Boffetta,et al.  Genetics of lung-cancer susceptibility. , 2011, The Lancet. Oncology.

[131]  M. Namlı,et al.  Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population , 2011, Genetics research international.

[132]  Xihong Lin,et al.  Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women. , 2011, Lung cancer.

[133]  R. Medeiros,et al.  Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk , 2011, Journal of Cancer Research and Clinical Oncology.

[134]  G. Gamble,et al.  Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD , 2011, PloS one.

[135]  Akira Mogi,et al.  TP53 Mutations in Nonsmall Cell Lung Cancer , 2011, Journal of biomedicine & biotechnology.

[136]  C. Shih,et al.  Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[137]  M. Thornquist,et al.  Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers , 2011, Cancer Causes & Control.

[138]  K. Sabapathy,et al.  Characterization of Novel and Uncharacterized p53 SNPs in the Chinese Population – Intron 2 SNP Co-Segregates with the Common Codon 72 Polymorphism , 2011, PloS one.

[139]  M. Spitz,et al.  Variants in folate pathway genes as modulators of genetic instability and lung cancer risk , 2011, Genes, chromosomes & cancer.

[140]  G. Gamble,et al.  FAM13A locus in COPD is independently associated with lung cancer – evidence of a molecular genetic link between COPD and lung cancer , 2010, The application of clinical genetics.

[141]  Yusuke Nakamura,et al.  A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. , 2010, Human molecular genetics.

[142]  F. Marincola,et al.  Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival , 2010, British Journal of Cancer.

[143]  H. Morgenstern,et al.  Single nucleotide polymorphisms of 8 inflammation‐related genes and their associations with smoking‐related cancers , 2010, International journal of cancer.

[144]  P. Balaram,et al.  CYP1A1m2 polymorphisms regulate estrogen and interleukin-6 in lung cancer. , 2010, Molecular medicine reports.

[145]  P. Chauhan,et al.  Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. , 2010, Genetic testing and molecular biomarkers.

[146]  Xin Zhou,et al.  Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[147]  Jenny Chang-Claude,et al.  Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early‐onset lung cancer , 2010, International journal of cancer.

[148]  G. Gervasini,et al.  CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study , 2010, BMC Cancer.

[149]  H. Morgenstern,et al.  Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. , 2010, Carcinogenesis.

[150]  Hongbing Shen,et al.  A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer. , 2010, Carcinogenesis.

[151]  B. Sivamaruthi,et al.  Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits , 2010, Human & experimental toxicology.

[152]  Yun Liu,et al.  Association of the CHRNA3 Locus with Lung Cancer Risk and Prognosis in Chinese Han Population , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[153]  Y. Pawitan,et al.  The pursuit of genome-wide association studies: where are we now? , 2010, Journal of Human Genetics.

[154]  A. Aynacioglu,et al.  Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. , 2010, Cancer genetics and cytogenetics.

[155]  K. Matsuo,et al.  Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population. , 2010, Carcinogenesis.

[156]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[157]  W. Nishio,et al.  Nonsynonymous single nucleotide polymorphisms in DNA damage repair pathways and lung cancer risk , 2010, Cancer.

[158]  P. Broderick,et al.  Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. , 2010, Carcinogenesis.

[159]  S. Toyooka,et al.  Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers , 2010, Journal of Cancer Research and Clinical Oncology.

[160]  K. Yoon,et al.  Genetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[161]  Baosen Zhou,et al.  ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females , 2009, Journal of experimental & clinical cancer research : CR.

[162]  D. Dobrota,et al.  Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population , 2009, European journal of medical research.

[163]  J. Cologne,et al.  Lung cancer susceptibility among atomic bomb survivors in relation to CA repeat number polymorphism of epidermal growth factor receptor gene and radiation dose. , 2009, Carcinogenesis.

[164]  Chih-Yi Chen,et al.  A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis. , 2009, International journal of molecular medicine.

[165]  Ying Wang,et al.  A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. , 2009, American journal of human genetics.

[166]  J. Schneider,et al.  CYP1A1 and CYP1B1 polymorphisms as modifying factors in patients with pneumoconiosis and occupationally related tumours: A pilot study. , 2009, Molecular medicine reports.

[167]  K. Matsuo,et al.  hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type , 2009, Journal of Human Genetics.

[168]  Bowang Chen,et al.  SNP_tools: A compact tool package for analysis and conversion of genotype data for MS-Excel , 2009, BMC Research Notes.

[169]  Hongbing Shen,et al.  Functional characterization of a promoter polymorphism in APE1/Ref‐1 that contributes to reduced lung cancer susceptibility , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[170]  C. Amos,et al.  Racial Differences in the Association Between SNPs on 15q25.1, Smoking Behavior, and Risk of Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[171]  P. Koul,et al.  CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population. , 2009, Asian Pacific journal of cancer prevention : APJCP.

[172]  G. Gamble,et al.  A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers , 2009, Postgraduate Medical Journal.

[173]  W. Tan,et al.  Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk , 2009, Human mutation.

[174]  R. Sobti,et al.  Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. , 2009, DNA and cell biology.

[175]  M. Spitz,et al.  Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. , 2009, Cancer research.

[176]  R. Houlston,et al.  The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. , 2009, Carcinogenesis.

[177]  K. Fong,et al.  Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer , 2009, European Respiratory Journal.

[178]  U. Vogel,et al.  HapMap-based study of the DNA repair gene ERCC2 and lung cancer susceptibility in a Chinese population. , 2009, Carcinogenesis.

[179]  J. Chang-Claude,et al.  CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. , 2009, Carcinogenesis.

[180]  H. Hsu,et al.  Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end‐joining pathway genes , 2009, Cancer.

[181]  P. Devilee,et al.  Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. , 2009, Cancer letters.

[182]  Wen Tan,et al.  Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. , 2009, Cancer research.

[183]  Nilanjan Chatterjee,et al.  Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression , 2009, PloS one.

[184]  S. Chanock,et al.  Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China , 2009, Environmental and molecular mutagenesis.

[185]  G. La Torre,et al.  GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. , 2009, Anticancer research.

[186]  Marshall W. Anderson,et al.  Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene , 2009, Clinical Cancer Research.

[187]  Hongbing Shen,et al.  A Functional Genetic Variant in microRNA-196a2 Is Associated with Increased Susceptibility of Lung Cancer in Chinese , 2009, Cancer Epidemiology Biomarkers & Prevention.

[188]  Hongbing Shen,et al.  Association between polymorphisms in the GSTA4 gene and risk of lung cancer: A case–control study in a Southeastern Chinese population , 2009, Molecular carcinogenesis.

[189]  Paolo Vineis,et al.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types , 2009, Nature Genetics.

[190]  Hongbing Shen,et al.  Genetic susceptibility of lung cancer associated with common variants in the 3′ untranslated regions of the adenosine triphosphate‐binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export , 2009, Cancer.

[191]  Hongbing Shen,et al.  Genetic variants in GTF2H1 and risk of lung cancer: a case-control analysis in a Chinese population. , 2009, Lung cancer.

[192]  T. Isbir,et al.  Association between manganese superoxide dismutase polymorphism and risk of lung cancer. , 2009, Cancer genetics and cytogenetics.

[193]  K. Osawa,et al.  MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population , 2009, Journal of experimental & clinical cancer research : CR.

[194]  Hongbing Shen,et al.  ERCC6/CSB gene polymorphisms and lung cancer risk. , 2009, Cancer letters.

[195]  Chien-Jen Chen,et al.  A Polymorphism in the APE1 Gene Promoter is Associated with Lung Cancer Risk , 2009, Cancer Epidemiology Biomarkers & Prevention.

[196]  D. Glavač,et al.  Somatic Alterations of the Serine/Threonine Kinase LKB1 Gene in Squamous Cell (SCC) and Large Cell (LCC) Lung Carcinoma , 2009, Cancer investigation.

[197]  Christopher I Amos,et al.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.

[198]  Hongbing Shen,et al.  Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population. , 2008, Lung cancer.

[199]  H. Morgenstern,et al.  Associations between Variants of the 8q24 Chromosome and Nine Smoking-Related Cancer Sites , 2008, Cancer Epidemiology Biomarkers & Prevention.

[200]  Xihong Lin,et al.  Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. , 2008, Carcinogenesis.

[201]  G. Gamble,et al.  Lung cancer gene associated with COPD: triple whammy or possible confounding effect? , 2008, European Respiratory Journal.

[202]  Hongbing Shen,et al.  Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. , 2008, Cancer research.

[203]  E. Shin,et al.  Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer. , 2008, Lung cancer.

[204]  J. Soh,et al.  The allelic distribution of a single nucleotide polymorphism in the PDCD5 gene locus of Japanese non-small cell lung cancer patients. , 2008, Molecular medicine reports.

[205]  M. Singh,et al.  Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. , 2008, Mutation research.

[206]  M. Ittmann,et al.  Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression. , 2008, Neoplasia.

[207]  Hongbing Shen,et al.  Genetic variants of miRNA sequences and non-small cell lung cancer survival. , 2008, The Journal of clinical investigation.

[208]  Jonathan Melamed,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[209]  D. Campa,et al.  A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. , 2008, Carcinogenesis.

[210]  Hongbing Shen,et al.  Polymorphisms in excision repair cross-complementing group 4 (ERCC4) and susceptibility to primary lung cancer in a Chinese Han population. , 2008, Lung cancer.

[211]  R. Ankathil,et al.  Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India , 2008, Journal of Cancer Research and Clinical Oncology.

[212]  W. Bamlet,et al.  Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. , 2008, Archives of internal medicine.

[213]  U. Vogel,et al.  Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population. , 2008, Mutation research.

[214]  Florian Kronenberg,et al.  Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[215]  W. Tan,et al.  Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis , 2008, Clinical Cancer Research.

[216]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[217]  K. Yoon,et al.  CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. , 2008, Lung cancer.

[218]  X. Liu,et al.  PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans. , 2008, The Journal of clinical investigation.

[219]  U. Vogel,et al.  Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. , 2008, Mutation research.

[220]  M. Singh,et al.  Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. , 2008, Mutation research.

[221]  A. Hofman,et al.  Renin‐angiotensin system inhibitors, angiotensin I‐converting enzyme gene insertion/deletion polymorphism, and cancer , 2008, Cancer.

[222]  Siobhan M. Dolan,et al.  Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.

[223]  U. Vogel,et al.  Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. , 2008, Lung cancer.

[224]  C. Lima,et al.  A polymorphism in the angiogenesis inhibitor, endostatin, in lung cancer susceptibility. , 2008, Lung cancer.

[225]  Xihong Lin,et al.  Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[226]  R. Ankathil,et al.  p53 Arg72Pro Polymorphism Predicts Survival Outcome in Lung Cancer Patients in Indian Population , 2008, Cancer investigation.

[227]  I. Oztop,et al.  Angiotensin-Converting Enzyme Gene Polymorphism Is Associated with Anemia in Non–Small-Cell Lung Cancer , 2008, Experimental biology and medicine.

[228]  J. Wakefield,et al.  Sequence Variants of NAT1 and NAT2 and Other Xenometabolic Genes and Risk of Lung and Aerodigestive Tract Cancers in Central Europe , 2008, Cancer Epidemiology Biomarkers & Prevention.

[229]  M. Spitz,et al.  ATM sequence variants associate with susceptibility to non‐small cell lung cancer , 2007, International journal of cancer.

[230]  E. Reszka,et al.  Antioxidant defense markers modulated by glutathione S-transferase genetic polymorphism: results of lung cancer case–control study , 2007, Genes & Nutrition.

[231]  S. Zienolddiny,et al.  Frequency of TP53 Mutations in Relation to Arg72Pro Genotypes in Non–Small Cell Lung Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[232]  M. Spitz,et al.  Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer , 2007, Clinical Cancer Research.

[233]  Zhou Bao-sen,et al.  Relationship between ERCC2 polymorphism and risk of lung cancer in Chinese nonsmoker , 2007 .

[234]  H. Shin,et al.  Genetic polymorphisms in the Rb-binding zinc finger gene RIZ and the risk of lung cancer. , 2007, Carcinogenesis.

[235]  A. Tardón,et al.  Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain , 2007, BMC Cancer.

[236]  M. Spitz,et al.  Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. , 2007, Lung cancer.

[237]  K. Matsuo,et al.  Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. , 2007, Carcinogenesis.

[238]  M. Lathrop,et al.  Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. , 2007, Carcinogenesis.

[239]  J. S. Lee,et al.  Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. , 2007, Lung cancer.

[240]  A. Gemma,et al.  Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite‐related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population , 2007, Cancer.

[241]  Zeyi Liu,et al.  No Association between TGFBR1*6A and Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[242]  F. Clavel-Chapelon,et al.  Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[243]  Ugo Pastorino,et al.  Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. , 2007, Cancer letters.

[244]  J. Ioannidis,et al.  An exploratory test for an excess of significant findings , 2007, Clinical trials.

[245]  Hongbing Shen,et al.  Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population , 2007, Pharmacogenetics and genomics.

[246]  U. Vogel,et al.  A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population. , 2007, Cancer genetics and cytogenetics.

[247]  M. Mahmoodi,et al.  An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. , 2007, Lung cancer.

[248]  J. Siegfried,et al.  Association of the EGFR intron 1 CA repeat length with lung cancer risk , 2007, Molecular carcinogenesis.

[249]  Ulla Vogel,et al.  The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. , 2007, Lung cancer.

[250]  Changqing Zeng,et al.  A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers , 2007, Nature Genetics.

[251]  J. Lafitte,et al.  Molecular analysis of the CYP2F1 gene: identification of a frequent non-functional allelic variant. , 2007, Mutation research.

[252]  U. Vogel,et al.  GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. , 2007, Cancer letters.

[253]  A. Tjønneland,et al.  Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer. , 2007, Lung cancer.

[254]  S. Chanock,et al.  Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung Tumors , 2007, Cancer Epidemiology Biomarkers & Prevention.

[255]  R. Sobti,et al.  Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population. , 2007, DNA and cell biology.

[256]  Rajiv Kumar,et al.  Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. , 2006, Lung cancer.

[257]  Changqing Zeng,et al.  Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression , 2006, Clinical Cancer Research.

[258]  Dong Sun Kim,et al.  Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population. , 2006, Lung cancer.

[259]  M. Spitz,et al.  Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites , 2006, Cancer Epidemiology Biomarkers & Prevention.

[260]  Il-Jin Kim,et al.  Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer. , 2006, Carcinogenesis.

[261]  R. Sobti,et al.  Impact of polymorphism in sulfotransferase gene on the risk of lung cancer. , 2006, Cancer genetics and cytogenetics.

[262]  Roger M Harbord,et al.  A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.

[263]  Satinder Kaur,et al.  Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population. , 2006, Cancer genetics and cytogenetics.

[264]  J. Park,et al.  MDM2 309T>G polymorphism and risk of lung cancer in a Korean population. , 2006, Lung cancer.

[265]  D. Neuberg,et al.  An association between glutathione S‐transferase P1 gene polymorphism and younger age at onset of lung carcinoma , 2006, Cancer.

[266]  U. Vogel,et al.  Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. , 2006, Free radical research.

[267]  J. Siegfried,et al.  Mutation and Polymorphism in the EGFR-TK Domain Associated with Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[268]  Dong Sun Kim,et al.  Polymorphisms in the caspase-8 gene and the risk of lung cancer. , 2006, Cancer genetics and cytogenetics.

[269]  Q. Wei,et al.  Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: a case-control study in a Chinese population. , 2006, Cancer letters.

[270]  R. Sobti,et al.  No association of DNA ligase-I polymorphism with the risk of lung cancer in north-Indian population. , 2006, DNA and cell biology.

[271]  J. Park,et al.  Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer. , 2006, Japanese journal of clinical oncology.

[272]  Hyo Jung Lee,et al.  Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population. , 2006, Cancer genetics and cytogenetics.

[273]  E. Bowman,et al.  MDM2 SNP309 and SNP354 Are Not Associated with Lung Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[274]  U. Pastorino,et al.  A V141L polymorphism of the human LRMP gene is associated with survival of lung cancer patients. , 2006, Carcinogenesis.

[275]  J. Park,et al.  Caspase 9 promoter polymorphisms and risk of primary lung cancer. , 2006, Human molecular genetics.

[276]  Jorma Järvisalo,et al.  EPHX1 gene polymorphisms and individual susceptibility to lung cancer. , 2006, Cancer letters.

[277]  T. Eisen,et al.  Variants in the GH-IGF axis confer susceptibility to lung cancer. , 2006, Genome research.

[278]  W. Poh,et al.  Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women. , 2006, Carcinogenesis.

[279]  F. Clavel-Chapelon,et al.  DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. , 2006, Carcinogenesis.

[280]  R. Catarino,et al.  A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. , 2006, European journal of cancer.

[281]  Xihong Lin,et al.  Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. , 2006, Carcinogenesis.

[282]  Ugo Pastorino,et al.  Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[283]  Å. Borg,et al.  Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. , 2006, Lung cancer.

[284]  D. Bishop,et al.  GSTM1 and CYP1A1 Polymorphisms, Tobacco, Air Pollution, and Lung Cancer: A Study in Rural Thailand , 2006, Cancer Epidemiology Biomarkers & Prevention.

[285]  S. Kam,et al.  Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study , 2006, BMC Cancer.

[286]  D. Campa,et al.  Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. , 2006, Carcinogenesis.

[287]  Wen Tan,et al.  Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer , 2006, Human mutation.

[288]  M. Chou,et al.  The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. , 2005, Lung cancer.

[289]  R. Ankathil,et al.  Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population , 2005, Journal of Human Genetics.

[290]  U. Pastorino,et al.  Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[291]  J. Schneider,et al.  XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. , 2005, International journal of molecular medicine.

[292]  Wei Guo,et al.  The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. , 2005, Carcinogenesis.

[293]  N. Rothman,et al.  Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China , 2005, International journal of cancer.

[294]  N. Rothman,et al.  Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. , 2005, Lung cancer.

[295]  M. Doroudchi,et al.  Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. , 2005, Lung cancer.

[296]  A. Tjønneland,et al.  A genetic polymorphism in prostaglandin synthase 2 (8473, T-->C) and the risk of lung cancer. , 2005, Cancer letters.

[297]  Qiuling Shi,et al.  Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case–control analysis , 2005, Pharmacogenetics and genomics.

[298]  W. Guo,et al.  No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. , 2005, Lung cancer.

[299]  C. Marsit,et al.  The race associated allele of Semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans. , 2005, Carcinogenesis.

[300]  Dong Sun Kim,et al.  No Association between Polymorphisms in the Histone Deacetylase Genes and the Risk of Lung Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[301]  T. Sellers,et al.  Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk. , 2005, Lung cancer.

[302]  W. Tan,et al.  Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer , 2005, Journal of Medical Genetics.

[303]  M. Spitz,et al.  Sex Differences in Risk of Lung Cancer Associated with Methylene-tetrahydrofolate Reductase Polymorphisms , 2005, Cancer Epidemiology Biomarkers & Prevention.

[304]  W. Tan,et al.  Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. , 2005, Carcinogenesis.

[305]  K. Matsuo,et al.  Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese. , 2005, Nagoya journal of medical science.

[306]  M. Tockman,et al.  Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[307]  U. Vogel,et al.  Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. , 2005, Cancer letters.

[308]  D. Pessayre,et al.  The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability , 2005, Pharmacogenetics and genomics.

[309]  J. Yokota,et al.  Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk , 2005, International journal of cancer.

[310]  Bin Zhao,et al.  CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation , 2005, Cancer Causes & Control.

[311]  A. Tjønneland,et al.  Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. , 2005, Cancer letters.

[312]  M. Spitz,et al.  An association between a NQO1 genetic polymorphism and risk of lung cancer. , 2005, Mutation research.

[313]  Y. Chang,et al.  Promoter −202 A/C polymorphism of insulin‐like growth factor binding protein‐3 gene and non‐small cell lung cancer risk , 2005, International journal of cancer.

[314]  A. Jakubowska,et al.  The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs , 2005 .

[315]  D. Christiani,et al.  Gene-Smoking Interaction Associations for the ERCC1 Polymorphisms in the Risk of Lung Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[316]  Q. Wei,et al.  Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. , 2005, Cancer research.

[317]  U. Vogel,et al.  No Association Between Base Excision Repair Gene Polymorphisms and Risk of Lung Cancer , 2004, Biochemical Genetics.

[318]  D. Neuberg,et al.  Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population , 2004, Cancer Causes & Control.

[319]  H. Dienemann,et al.  Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. , 2004, Carcinogenesis.

[320]  J. Park,et al.  −93G→A polymorphism of hMLH1 and risk of primary lung cancer , 2004, International journal of cancer.

[321]  Thomas A Trikalinos,et al.  'Racial' differences in genetic effects for complex diseases , 2004, Nature Genetics.

[322]  A. Tardón,et al.  Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[323]  R. Sobti,et al.  Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population , 2004, Molecular and Cellular Biochemistry.

[324]  S. Wacholder,et al.  CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. , 2004, Cancer letters.

[325]  Y. Yamashita,et al.  Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms. , 2004, Oncology reports.

[326]  W. Bamlet,et al.  Glutathione pathway genes and lung cancer risk in young and old populations. , 2004, Carcinogenesis.

[327]  Qiuling Shi,et al.  Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. , 2004, Carcinogenesis.

[328]  Marshall W. Anderson,et al.  A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.

[329]  Shu-qing Chen,et al.  Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population. , 2004, World journal of gastroenterology.

[330]  A. Tjønneland,et al.  Glutathione S‐transferase T1 null‐genotype is associated with an increased risk of lung cancer , 2004, International journal of cancer.

[331]  J. Schneider,et al.  GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. , 2004, Cancer letters.

[332]  K. Buetow,et al.  Genetic susceptibility and dietary patterns in lung cancer. , 2004, Lung cancer.

[333]  Hue Lee,et al.  Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. , 2004, Toxicology letters.

[334]  F. Canzian,et al.  Polymorphisms of the interleukin‐1 β gene are associated with increased risk of non‐small cell lung cancer , 2004, International journal of cancer.

[335]  K. Lisowska,et al.  Intronic polymorphism (1541‐1542delGT) of the constitutive heat shock protein 70 gene has functional significance and shows evidence of association with lung cancer risk , 2004, Molecular carcinogenesis.

[336]  U. Vogel,et al.  Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. , 2004, Mutation research.

[337]  T. Dragani,et al.  A new polymorphism (Ser362Thr) of the L-myc gene is not associated with lung adenocarcinoma risk and prognosis , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[338]  Jong Y. Park,et al.  The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. , 2004, Pharmacogenetics.

[339]  Jingweng Wang,et al.  GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. , 2003, Cancer letters.

[340]  W. Tan,et al.  Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. , 2003, Cancer research.

[341]  I. Yaylim,et al.  GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas. , 2003, In vivo.

[342]  Z. Seyfikli,et al.  Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. , 2003, Cancer genetics and cytogenetics.

[343]  M. Spitz,et al.  XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations , 2003, Cancer.

[344]  M. Spitz,et al.  Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. , 2003, Lung cancer.

[345]  Shi Qiuling,et al.  Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. , 2003, Carcinogenesis.

[346]  A. Janmeja,et al.  CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population , 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[347]  A. Ruano-Raviña,et al.  GSTM1 and GSTT1 polymorphisms, tobacco and risk of lung cancer: a case-control study from Galicia, Spain. , 2003, Anticancer research.

[348]  J. Gmiński,et al.  Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. , 2003, Oncology reports.

[349]  T. Vaughan,et al.  A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. , 2003, Lung cancer.

[350]  Q. Qi,et al.  Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer. , 2003, Lung cancer.

[351]  K. Kuriki,et al.  Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: A case‐control study in Chinese population , 2003, Cancer science.

[352]  Jan-Gowth Chang,et al.  CYP3A5* 1 is an Inhibitory Factor for Lung Cancer in Taiwanese , 2003, The Kaohsiung journal of medical sciences.

[353]  D. Christiani,et al.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[354]  M. Spitz,et al.  Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. , 2003, Lung cancer.

[355]  D. Albanes,et al.  Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. , 2003, Cancer letters.

[356]  M. Spitz,et al.  XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. , 2003, Carcinogenesis.

[357]  D. Christiani,et al.  No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[358]  D. Isla,et al.  MDR-1 C3435T Genetic Polymorphism and Tobacco-Related Lung Cancer , 2003, Oncology.

[359]  D. Christiani,et al.  Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[360]  W. Tan,et al.  Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population , 2002, International journal of cancer.

[361]  W. Tan,et al.  Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. , 2002, Cancer research.

[362]  A. Cittadini,et al.  Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. , 2002, Anticancer research.

[363]  Q. Wei,et al.  Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. , 2002, Lung cancer.

[364]  D. Spandidos,et al.  Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes , 2002, British Journal of Cancer.

[365]  P. Shields.  Molecular epidemiology of smoking and lung cancer , 2002, Oncogene.

[366]  David H Phillips,et al.  Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. , 2002, Carcinogenesis.

[367]  J. Park,et al.  Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[368]  M. Loriot,et al.  Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. , 2002, Carcinogenesis.

[369]  Hongbing Shen,et al.  A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. , 2002, Cancer research.

[370]  C. Weinberg,et al.  Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. , 2002, American journal of epidemiology.

[371]  J. Yokota,et al.  Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[372]  U. Seifart,et al.  Surfactant protein B gene variations enhance susceptibility to squamous cell carcinoma of the lung in German patients , 2002, British Journal of Cancer.

[373]  M. Spitz,et al.  A myeloperoxidase polymorphism associated with reduced risk of lung cancer. , 2002, Lung cancer.

[374]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[375]  Hongbing Shen,et al.  Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. , 2002, Lung cancer.

[376]  D. Christiani,et al.  Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. , 2002, Cancer research.

[377]  M. Spitz,et al.  p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. , 2002, Journal of the National Cancer Institute.

[378]  C. Shih,et al.  Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases. , 2002, Lung cancer.

[379]  J. Park,et al.  Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. , 2002, Lung cancer.

[380]  Claude Deschamps,et al.  Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[381]  D. Christiani,et al.  Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. , 2002, Cancer research.

[382]  Hua Zhao,et al.  Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non‐Hispanic whites , 2002, Molecular carcinogenesis.

[383]  M. Spitz,et al.  Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. , 2002, Lung cancer.

[384]  L. Quiñones,et al.  CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. , 2001, Cancer letters.

[385]  D. Christiani,et al.  Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. , 2001, Journal of the National Cancer Institute.

[386]  H. Dienemann,et al.  Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. , 2001, Pharmacogenetics.

[387]  J. Gómez-catalán,et al.  Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. , 2001, Cancer letters.

[388]  J. Gmiński,et al.  Fibronectin gene polymorphism in patients with lung cancer. , 2001, Oncology reports.

[389]  G. Mills,et al.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. , 2001, Cancer research.

[390]  M. Teh,et al.  Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[391]  L. Yin,et al.  Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. , 2001, Lung cancer.

[392]  C I Amos,et al.  The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. , 2001, Carcinogenesis.

[393]  P. Schraml,et al.  A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer. , 2001, Lung cancer.

[394]  Hongbing Shen,et al.  Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[395]  M. Teh,et al.  Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore. , 2001, Carcinogenesis.

[396]  D. Albanes,et al.  Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. , 2001, Cancer letters.

[397]  W. Tan,et al.  Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population , 2001, International journal of cancer.

[398]  H. Dienemann,et al.  Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. , 2001, Pharmacogenetics.

[399]  D. Albanes,et al.  Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking--lung cancer association. , 2001, Anticancer research.

[400]  C I Amos,et al.  Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. , 2001, Cancer research.

[401]  M. Loriot,et al.  Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. , 2001, Pharmacogenetics.

[402]  M. Tockman,et al.  Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[403]  H. Dienemann,et al.  hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population , 2000, International journal of cancer.

[404]  D. Albanes,et al.  Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. , 2000, Cancer research.

[405]  L. Le Marchand,et al.  Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[406]  M. Spitz,et al.  Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[407]  M. Spitz,et al.  D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[408]  G. Coetzee,et al.  CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[409]  G. Coetzee,et al.  Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China , 2000, The Lancet.

[410]  W. Ahrens,et al.  Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[411]  S. London,et al.  Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. , 2000, Lung cancer.

[412]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[413]  E. Imyanitov,et al.  L‐myc polymorphism in cancer patients, healthy blood donors and elderly, tumor‐free individuals in Russia , 2000, International journal of cancer.

[414]  S. Anttila,et al.  Role of NAT2 deficiency in susceptibility to lung cancer among asbestos-exposed individuals. , 2000, Pharmacogenetics.

[415]  L. Le Marchand,et al.  Association of the myeloperoxidase -463G-->a polymorphism with lung cancer risk. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[416]  O. Gotoh,et al.  Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. , 2000, Pharmacogenetics.

[417]  G. Marfany,et al.  Polymorphism of glutathione S-transferase M3: interaction with glutathione S-transferase M1 and lung cancer susceptibility , 2000, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[418]  C. Shih,et al.  Lack of Evidence of Association of p21WAF1/CIP1 Polymorphism with Lung Cancer Susceptibility and Prognosis in Taiwan , 2000, Japanese journal of cancer research : Gann.

[419]  N. Bhat,et al.  Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers. , 1999, Cancer Epidemiology, Biomarkers and Prevention.

[420]  K. Tsai,et al.  Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. , 1999, Lung cancer.

[421]  M. Teh,et al.  NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore. , 1999, Carcinogenesis.

[422]  J. Yokota,et al.  CYP2A6 gene deletion reduces susceptibility to lung cancer. , 1999, Biochemical and biophysical research communications.

[423]  B. Morris,et al.  hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[424]  R. Rosell,et al.  Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[425]  M. Ingelman-Sundberg,et al.  Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients , 1999, International journal of cancer.

[426]  J. Gómez-catalán,et al.  Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk , 1999, Cancer Causes & Control.

[427]  F P Perera,et al.  Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. , 1998, Carcinogenesis.

[428]  S. Anttila,et al.  Combined effect of polymorphic GST genes on individual susceptibility to lung cancer , 1998, International journal of cancer.

[429]  B. Morris,et al.  Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[430]  E. Taioli,et al.  Lung cancer risk and CYP1A1 genotype in African Americans. , 1998, Carcinogenesis.

[431]  M. Spitz,et al.  Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.

[432]  M. Tucker,et al.  Genetic polymorphism of CYP2D6 and lung cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[433]  H. Shirasawa,et al.  Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients. , 1998, International journal of oncology.

[434]  S J London,et al.  Myeloperoxidase genetic polymorphism and lung cancer risk. , 1997, Cancer research.

[435]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[436]  T. Dragani,et al.  Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. , 1997, Carcinogenesis.

[437]  S. London,et al.  Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County. , 1997, Pharmacogenetics.

[438]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[439]  J. Gómez-catalán,et al.  Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. , 1997, Carcinogenesis.

[440]  L. Harries,et al.  Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. , 1997, Carcinogenesis.

[441]  M. Spitz,et al.  Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. , 1997, Carcinogenesis.

[442]  H. Issaq,et al.  Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls. , 1997, Lung cancer.

[443]  R. Brownson,et al.  Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers. , 1997, International journal of epidemiology.

[444]  J. Pi,et al.  Gene deficiency of glutathione S-transferase mu isoform associated with susceptibility to lung cancer in a Chinese population. , 1997, Cancer letters.

[445]  M. Spitz,et al.  Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[446]  S. London,et al.  Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. , 1996, Pharmacogenetics.

[447]  Yasuhiro Watanabe,et al.  Genotype analysis of the CYP2C19 gene in the Japanese population. , 1996, Life sciences.

[448]  D. Christiani,et al.  Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[449]  R. Birgander,et al.  Association between the p21 codon 31 A1 (arg) allele and lung cancer. , 1996, Human heredity.

[450]  C. Galán,et al.  Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[451]  S. London,et al.  Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. , 1996, Pharmacogenetics.

[452]  S. London,et al.  Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. , 1995, Cancer research.

[453]  P. Beaune,et al.  CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure. , 1995, Carcinogenesis.

[454]  K. Nakachi,et al.  Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation. , 1995, Carcinogenesis.

[455]  S. London,et al.  Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. , 1995, Journal of the National Cancer Institute.

[456]  K. Buetow,et al.  Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. , 1995, Pharmacogenetics.

[457]  K. Nakachi,et al.  An Rsa I Polymorphism in the CYP2E1 Gene Does Not Affect Lung Cancer Risk in a Japanese Population , 1995, Japanese journal of cancer research : Gann.

[458]  A. Brøgger,et al.  Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls. , 1994, Pharmacogenetics.

[459]  R. Hoover,et al.  Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. , 1994, Carcinogenesis.

[460]  R. Kanamaru,et al.  Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. , 1994, Pharmacogenetics.

[461]  R. Hoover,et al.  Lung cancer, race, and a CYP1A1 genetic polymorphism. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[462]  K. Nakachi,et al.  Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. , 1993, Cancer research.

[463]  R. Rylander,et al.  Genetic polymorphism of cytochrome P4502E1 in a Swedish population , 1993, FEBS letters.

[464]  R. Hoover,et al.  Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. , 1992, Environmental health perspectives.

[465]  D. Ryberg,et al.  Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients. , 1992, Environmental health perspectives.

[466]  R. Hoover,et al.  Allelic frequency of a p53 polymorphism in human lung cancer. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[467]  C. Smith,et al.  Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. , 1992, Carcinogenesis.

[468]  K. Nakachi,et al.  Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. , 1991, Cancer research.

[469]  C. Wolf,et al.  Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. , 1991, Carcinogenesis.

[470]  J. Resau,et al.  Restriction fragment length polymorphism analysis of the l‐myc gene locus in a case‐control study of lung cancer , 1990, International journal of cancer.

[471]  A. Brøgger,et al.  Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients. , 1990, British Journal of Cancer.

[472]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[473]  E. Halasová,et al.  Polymorphisms of DNA repair genes and lung cancer in chromium exposure. , 2015, Advances in experimental medicine and biology.

[474]  E. Halasová,et al.  Mismatch repair gene polymorphisms and association with lung cancer development. , 2015, Advances in experimental medicine and biology.

[475]  Baosen Zhou,et al.  Common genetic variants in 53BP1 associated with nonsmall-cell lung cancer risk in Han Chinese. , 2014, Archives of medical research.

[476]  Baosen Zhou,et al.  PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer. , 2014, Genetic testing and molecular biomarkers.

[477]  Baosen Zhou,et al.  Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[478]  Wei Wu,et al.  P53 Arg72Pro and MDM2 SNP309 polymorphisms cooperate to increase lung adenocarcinoma risk in Chinese female non-smokers: a case control study. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[479]  Youngchul Kim,et al.  Glutathione-S-transferase (GSTM1, GSTT1) null phenotypes and risk of lung cancer in a Korean population. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[480]  A. Farooqi,et al.  Re-evaluating the FGFR4 (G388R) germline mutation in different cancers in Pakistani population. , 2013, Journal of experimental therapeutics & oncology.

[481]  yongjun zhang,et al.  Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers. , 2013, Clinical lung cancer.

[482]  Wei-hong Chen 陈卫红,et al.  Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: A case-control study , 2013, Journal of Huazhong University of Science and Technology [Medical Sciences].

[483]  M. Thornquist,et al.  Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. , 2012, International journal of molecular epidemiology and genetics.

[484]  M. Hiratsuka,et al.  Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. , 2011, Drug metabolism and pharmacokinetics.

[485]  M. Ramzy,et al.  Genetic polymorphism of GSTM1 and GSTP1 in lungcancer in Egypt , 2011 .

[486]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[487]  P. Shah,et al.  Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men. , 2010, Cancer biomarkers : section A of Disease markers.

[488]  D. Moura,et al.  CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer. , 2010, Revista portuguesa de pneumologia.

[489]  Dong-Li Xu,et al.  The relationship between three heat shock protein 70 gene polymorphisms and susceptibility to lung cancer , 2010, Clinical chemistry and laboratory medicine.

[490]  Chiaki Nakarai,et al.  APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[491]  Hongbing Shen,et al.  Candidate variants at 6p21.33 and 6p22.1 and risk of non-small cell lung cancer in a Chinese population. , 2010, International journal of molecular epidemiology and genetics.

[492]  Ryan Hunt,et al.  Silent (synonymous) SNPs: should we care about them? , 2009, Methods in molecular biology.

[493]  Tao Zhang 张 涛,et al.  The association between RASSF1 gene polymorphisms and lung cancer susceptibility among people in Hubei Province of China , 2009, Journal of Huazhong University of Science and Technology [Medical Sciences].

[494]  J. Yokota,et al.  Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. , 2009, Carcinogenesis.

[495]  A. Tomovic,et al.  TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. , 2009, Neoplasma.

[496]  R. Moslehi,et al.  Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer. , 2009, Cancer detection and prevention.

[497]  J. Milanowski,et al.  CYP1A1, GSTT1, and GSTM1 Polymorphisms and Lung Cancer in Eastern Poland , 2009 .

[498]  R. Ankathil,et al.  Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. , 2008, Journal of experimental therapeutics & oncology.

[499]  R. Sobti,et al.  Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer. , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[500]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[501]  Marshall W. Anderson,et al.  Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. , 2007, Cancer research.

[502]  H. Dienemann,et al.  Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms. , 2007, Lung cancer.

[503]  K. Osawa,et al.  NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. , 2007, Asian Pacific journal of cancer prevention : APJCP.

[504]  V. Lyakhovich,et al.  Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer , 2007, Bulletin of Experimental Biology and Medicine.

[505]  John Ioannidis,et al.  The HuGENetTM HuGE Review Handbook, version 1.0 , 2006 .

[506]  M. Chou,et al.  Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. , 2006, Lung cancer.

[507]  J. Park,et al.  Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population. , 2006, Cancer detection and prevention.

[508]  L. Melton,et al.  Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. , 2005, Chest.

[509]  N. Rothman,et al.  Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. , 2005, Anticancer research.

[510]  C. H. Kim,et al.  Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[511]  W. Tan,et al.  CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. , 2001, Carcinogenesis.

[512]  P. Lin,et al.  p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[513]  E. Biros,et al.  Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. , 1998, Neoplasma.

[514]  M. Spitz,et al.  Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[515]  T. Mitsudomi,et al.  N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. , 1997, Anticancer research.

[516]  T. Mitsudomi,et al.  Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. , 1997, Anticancer research.

[517]  J. Rueff,et al.  Glutathione S-transferase mu polymorphism and susceptibility to lung cancer in the Portuguese population. , 1996, Teratogenesis, carcinogenesis, and mutagenesis.

[518]  S. Tsugane,et al.  CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil. , 1995, Pharmacogenetics.

[519]  G. Gamble,et al.  The Application of Clinical Genetics Dovepress Gstm1 Null Genotype in Copd and Lung Cancer: Evidence of a Modifier or Confounding Effect? , 2022 .